Results 261 to 270 of about 3,314,611 (329)
Innate and adaptive immune responses in Hepatitis C virus infections. [PDF]
Kishida Y.
europepmc +1 more source
Objective This study aimed to characterize the pharmacokinetics, pharmacodynamics, safety, and exploratory efficacy of subcutaneous belimumab in pediatric patients with active systemic lupus erythematosus (SLE) receiving standard therapy. Methods This single‐arm, multicenter, open‐label trial (GSK study 200908; NCT04179032) used three‐weight‐band ...
Hermine I. Brunner +14 more
wiley +1 more source
Innate immunity in tumors: roles and therapeutic targets. [PDF]
Leng S +7 more
europepmc +1 more source
Objective We aimed to validate the Pediatric Arthritis Ultrasound Scoring System (PAUSS) for upper extremity joints in children with juvenile idiopathic arthritis (JIA). Methods Children with JIA were evaluated for elbow, wrist, or finger arthritis by clinical examination (CE) and musculoskeletal ultrasound (MSUS) with images scored according to the ...
Patricia Vega‐Fernandez +12 more
wiley +1 more source
Liver as a key organ for systemic antimicrobial defense. [PDF]
Yao T +4 more
europepmc +1 more source
Objectives Sjögren's disease is an autoimmune disorder that can impact multiple organ systems, including the peripheral nervous system (PNS). PNS manifestations, which can exist concurrently, include mononeuropathies, polyneuropathies, and autonomic nervous system neuropathies. To help patients and providers in the decision‐making process, we developed
Anahita Deboo +19 more
wiley +1 more source
Towards antibody-based immunotherapy development for platinum-resistant high-grade serous ovarian cancer. [PDF]
Giedraityte Z +2 more
europepmc +1 more source
Complement-mediated and direct activation of human neutrophils induced by <i>Premolis semirufa</i> caterpillar toxins. [PDF]
Gabrili JJM +4 more
europepmc +1 more source
Complement C3 in panvascular disease: a central integrator of immune signaling and vascular remodeling. [PDF]
Li Y, Zeng H, Zhong X.
europepmc +1 more source

